{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:38:48Z","timestamp":1791754728256,"version":"4.3.4"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00401-019-02055-3","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T01:32:35Z","timestamp":1567128755000},"page":"669-687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["An update on the central nervous system manifestations of Li\u2013Fraumeni syndrome"],"prefix":"10.1007","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0997-4728","authenticated-orcid":false,"given":"Brent A.","family":"Orr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Clay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia M.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chimene","family":"Kesserwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,30]]},"reference":[{"key":"2055_CR1","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1080\/02841860802047411","volume":"47","author":"J Alsner","year":"2008","unstructured":"Alsner J, Jensen V, Kyndi M, Offersen BV, Vu P, Borresen-Dale AL et al (2008) A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients. Acta Oncol 47:600\u2013607. \nhttps:\/\/doi.org\/10.1080\/02841860802047411","journal-title":"Acta Oncol"},{"key":"2055_CR2","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/ng.994","volume":"43","author":"MF Amary","year":"2011","unstructured":"Amary MF, Damato S, Halai D, Eskandarpour M, Berisha F, Bonar F et al (2011) Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet 43:1262\u20131265. \nhttps:\/\/doi.org\/10.1038\/ng.994","journal-title":"Nat Genet"},{"key":"2055_CR3","first-page":"3013","volume":"35","author":"M Bahar","year":"2015","unstructured":"Bahar M, Kordes U, Tekautz T, Wolff J (2015) Radiation therapy for choroid plexus carcinoma patients with Li\u2013Fraumeni syndrome: advantageous or detrimental? Anticancer Res 35:3013\u20133017","journal-title":"Anticancer Res"},{"key":"2055_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1126\/science.2649981","volume":"244","author":"SJ Baker","year":"1989","unstructured":"Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM et al (1989) Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244:217\u2013221","journal-title":"Science"},{"key":"2055_CR5","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1101\/gad.6.10.1886","volume":"6","author":"J Bargonetti","year":"1992","unstructured":"Bargonetti J, Reynisdottir I, Friedman PN, Prives C (1992) Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes Dev 6:1886\u20131898","journal-title":"Genes Dev"},{"key":"2055_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/cam4.561","volume":"5","author":"MR Bazrafshani","year":"2016","unstructured":"Bazrafshani MR, Nowshadi PA, Shirian S, Daneshbod Y, Nabipour F, Mokhtari M et al (2016) Deletion\/duplication mutation screening of TP53 gene in patients with transitional cell carcinoma of urinary bladder using multiplex ligation-dependent probe amplification. Cancer Med 5:145\u2013152. \nhttps:\/\/doi.org\/10.1002\/cam4.561","journal-title":"Cancer Med"},{"key":"2055_CR7","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1126\/science.286.5449.2528","volume":"286","author":"DW Bell","year":"1999","unstructured":"Bell DW, Varley JM, Szydlo TE, Kang DH, Wahrer DC, Shannon KE et al (1999) Heterozygous germ line hCHK2 mutations in Li\u2013Fraumeni syndrome. Science 286:2528\u20132531","journal-title":"Science"},{"key":"2055_CR8","first-page":"1298","volume":"54","author":"JM Birch","year":"1994","unstructured":"Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM et al (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li\u2013Fraumeni families. Cancer Res 54:1298\u20131304","journal-title":"Cancer Res"},{"key":"2055_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jama.1979.03290290027019","volume":"241","author":"WA Blattner","year":"1979","unstructured":"Blattner WA, McGuire DB, Mulvihill JJ, Lampkin BC, Hananian J, Fraumeni JF (1979) Genealogy of cancer in a family. JAMA 241:259\u2013261","journal-title":"JAMA"},{"key":"2055_CR10","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1158\/0008-5472.CAN-06-0180","volume":"66","author":"GL Bond","year":"2006","unstructured":"Bond GL, Hirshfield KM, Kirchhoff T, Alexe G, Bond EE, Robins H et al (2006) MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner. Cancer Res 66:5104\u20135110. \nhttps:\/\/doi.org\/10.1158\/0008-5472.CAN-06-0180","journal-title":"Cancer Res"},{"key":"2055_CR11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.cell.2004.11.022","volume":"119","author":"GL Bond","year":"2004","unstructured":"Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC et al (2004) A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119:591\u2013602. \nhttps:\/\/doi.org\/10.1016\/j.cell.2004.11.022","journal-title":"Cell"},{"key":"2055_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/00019606-199512000-00004","volume":"4","author":"S Bosari","year":"1995","unstructured":"Bosari S, Marchetti A, Buttitta F, Graziani D, Borsani G, Loda M et al (1995) Detection of p53 mutations by single-strand conformation polymorphisms (SSCP) gel electrophoresis. A comparative study of radioactive and nonradioactive silver-stained SSCP analysis. Diagn Mol Pathol 4:249\u2013255","journal-title":"Diagn Mol Pathol"},{"key":"2055_CR13","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/humu.23035","volume":"37","author":"L Bouaoun","year":"2016","unstructured":"Bouaoun L, Sonkin D, Ardin M, Hollstein M, Byrnes G, Zavadil J et al (2016) TP53 variations in human cancers: new lessons from the IARC TP53 database and genomics data. Hum Mutat 37:865\u2013876. \nhttps:\/\/doi.org\/10.1002\/humu.23035","journal-title":"Hum Mutat"},{"key":"2055_CR14","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","volume":"33","author":"G Bougeard","year":"2015","unstructured":"Bougeard G, Renaux-Petel M, Flaman JM, Charbonnier C, Fermey P, Belotti M et al (2015) Revisiting Li\u2013Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol 33:2345\u20132352. \nhttps:\/\/doi.org\/10.1200\/JCO.2014.59.5728","journal-title":"J Clin Oncol"},{"key":"2055_CR15","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","volume":"155","author":"CW Brennan","year":"2013","unstructured":"Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR et al (2013) The somatic genomic landscape of glioblastoma. Cell 155:462\u2013477. \nhttps:\/\/doi.org\/10.1016\/j.cell.2013.09.034","journal-title":"Cell"},{"key":"2055_CR16","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/sj.onc.1203434","volume":"19","author":"AN Bullock","year":"2000","unstructured":"Bullock AN, Henckel J, Fersht AR (2000) Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy. Oncogene 19:1245\u20131256. \nhttps:\/\/doi.org\/10.1038\/sj.onc.1203434","journal-title":"Oncogene"},{"key":"2055_CR17","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/nejmoa1402121","volume":"372","author":"DJ Brat","year":"2015","unstructured":"Cancer Genome Atlas Research N, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481\u20132498. \nhttps:\/\/doi.org\/10.1056\/nejmoa1402121","journal-title":"N Engl J Med"},{"key":"2055_CR18","doi-asserted-by":"publisher","DOI":"10.1200\/po.17.00011","author":"D Chakravarty","year":"2017","unstructured":"Chakravarty D, Gao J, Phillips SM, Kundra R, Zhang H, Wang J et al (2017) OncoKB: a precision oncology knowledge base. JCO Precis Oncol. \nhttps:\/\/doi.org\/10.1200\/po.17.00011","journal-title":"JCO Precis Oncol"},{"key":"2055_CR19","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1101\/gad.7.10.1837","volume":"7","author":"X Chen","year":"1993","unstructured":"Chen X, Farmer G, Zhu H, Prywes R, Prives C (1993) Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation. Genes Dev 7:1837\u20131849","journal-title":"Genes Dev"},{"key":"2055_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/jmg.38.1.43","volume":"38","author":"A Chompret","year":"2001","unstructured":"Chompret A, Abel A, Stoppa-Lyonnet D, Brugieres L, Pages S, Feunteun J et al (2001) Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet 38:43\u201347","journal-title":"J Med Genet"},{"key":"2055_CR21","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.jmb.2003.08.008","volume":"332","author":"R Dawson","year":"2003","unstructured":"Dawson R, Muller L, Dehner A, Klein C, Kessler H, Buchner J (2003) The N-terminal domain of p53 is natively unfolded. J Mol Biol 332:1131\u20131141","journal-title":"J Mol Biol"},{"key":"2055_CR22","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/humu.23320","volume":"38","author":"KC de Andrade","year":"2017","unstructured":"de Andrade KC, Mirabello L, Stewart DR, Karlins E, Koster R, Wang M et al (2017) Higher-than-expected population prevalence of potentially pathogenic germline TP53 variants in individuals unselected for cancer history. Hum Mutat 38:1723\u20131730. \nhttps:\/\/doi.org\/10.1002\/humu.23320","journal-title":"Hum Mutat"},{"key":"2055_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/356215a0","volume":"356","author":"LA Donehower","year":"1992","unstructured":"Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS et al (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215\u2013221. \nhttps:\/\/doi.org\/10.1038\/356215a0","journal-title":"Nature"},{"key":"2055_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/ng1093","volume":"33","author":"P Dumont","year":"2003","unstructured":"Dumont P, Leu JI, Della Pietra AC III, George DL, Murphy M (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33:357\u2013365. \nhttps:\/\/doi.org\/10.1038\/ng1093","journal-title":"Nat Genet"},{"key":"2055_CR25","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/cncr.10189","volume":"94","author":"CG Eberhart","year":"2002","unstructured":"Eberhart CG, Kepner JL, Goldthwaite PT, Kun LE, Duffner PK, Friedman HS et al (2002) Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study. Cancer 94:552\u2013560. \nhttps:\/\/doi.org\/10.1002\/cncr.10189","journal-title":"Cancer"},{"key":"2055_CR26","first-page":"101","volume":"25","author":"RA Eeles","year":"1995","unstructured":"Eeles RA (1995) Germline mutations in the TP53 gene. Cancer Surv 25:101\u2013124","journal-title":"Cancer Surv"},{"key":"2055_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ng0492-45","volume":"1","author":"WS El-Deiry","year":"1992","unstructured":"El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B (1992) Definition of a consensus binding site for p53. Nat Genet 1:45\u201349. \nhttps:\/\/doi.org\/10.1038\/ng0492-45","journal-title":"Nat Genet"},{"key":"2055_CR28","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1200\/JCO.2010.30.2810","volume":"29","author":"DW Ellison","year":"2011","unstructured":"Ellison DW, Kocak M, Dalton J, Megahed H, Lusher ME, Ryan SL et al (2011) Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. J Clin Oncol 29:1400\u20131407. \nhttps:\/\/doi.org\/10.1200\/JCO.2010.30.2810","journal-title":"J Clin Oncol"},{"key":"2055_CR29","first-page":"752","volume":"53","author":"E Felley-Bosco","year":"1993","unstructured":"Felley-Bosco E, Weston A, Cawley HM, Bennett WP, Harris CC (1993) Functional studies of a germ-line polymorphism at codon 47 within the p53 gene. Am J Hum Genet 53:752\u2013759","journal-title":"Am J Hum Genet"},{"key":"2055_CR30","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1126\/science.2144363","volume":"249","author":"S Fields","year":"1990","unstructured":"Fields S, Jang SK (1990) Presence of a potent transcription activating sequence in the p53 protein. Science 249:1046\u20131049","journal-title":"Science"},{"key":"2055_CR31","doi-asserted-by":"publisher","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","volume":"45","author":"SA Forbes","year":"2017","unstructured":"Forbes SA, Beare D, Boutselakis H, Bamford S, Bindal N, Tate J et al (2017) COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res 45:D777\u2013D783. \nhttps:\/\/doi.org\/10.1093\/nar\/gkw1121","journal-title":"Nucleic Acids Res"},{"key":"2055_CR32","first-page":"608","volume":"56","author":"T Frebourg","year":"1995","unstructured":"Frebourg T, Barbier N, Yan YX, Garber JE, Dreyfus M, Fraumeni J Jr et al (1995) Germ-line p53 mutations in 15 families with Li\u2013Fraumeni syndrome. Am J Hum Genet 56:608\u2013615","journal-title":"Am J Hum Genet"},{"key":"2055_CR33","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1002\/1097-0142(19901215)66:12<2658::AID-CNCR2820661232>3.0.CO;2-C","volume":"66","author":"JE Garber","year":"1990","unstructured":"Garber JE, Burke EM, Lavally BL, Billett AL, Sallan SE, Scott RM et al (1990) Choroid plexus tumors in the breast cancer-sarcoma syndrome. Cancer 66:2658\u20132660","journal-title":"Cancer"},{"key":"2055_CR34","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1038\/sj.onc.1207305","volume":"23","author":"F Gemignani","year":"2004","unstructured":"Gemignani F, Moreno V, Landi S, Moullan N, Chabrier A, Gutierrez-Enriquez S et al (2004) A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA. Oncogene 23:1954\u20131956. \nhttps:\/\/doi.org\/10.1038\/sj.onc.1207305","journal-title":"Oncogene"},{"key":"2055_CR35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13059-017-1353-5","volume":"18","author":"R Ghosh","year":"2017","unstructured":"Ghosh R, Oak N, Plon SE (2017) Evaluation of in silico algorithms for use with ACMG\/AMP clinical variant interpretation guidelines. Genome Biol 18:225. \nhttps:\/\/doi.org\/10.1186\/s13059-017-1353-5","journal-title":"Genome Biol"},{"key":"2055_CR36","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3171\/jns.1999.91.6.0971","volume":"91","author":"F Giangaspero","year":"1999","unstructured":"Giangaspero F, Perilongo G, Fondelli MP, Brisigotti M, Carollo C, Burnelli R et al (1999) Medulloblastoma with extensive nodularity: a variant with favorable prognosis. J Neurosurg 91:971\u2013977. \nhttps:\/\/doi.org\/10.3171\/jns.1999.91.6.0971","journal-title":"J Neurosurg"},{"key":"2055_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11060-014-1407-4","volume":"118","author":"E Gillet","year":"2014","unstructured":"Gillet E, Alentorn A, Doukoure B, Mundwiller E, van Thuijl HF, Reijneveld JC et al (2014) TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas. J Neurooncol 118:131\u2013139. \nhttps:\/\/doi.org\/10.1007\/s11060-014-1407-4","journal-title":"J Neurooncol"},{"key":"2055_CR38","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1200\/JCO.2008.16.6959","volume":"27","author":"KD Gonzalez","year":"2009","unstructured":"Gonzalez KD, Noltner KA, Buzin CH, Gu D, Wen-Fong CY, Nguyen VQ et al (2009) Beyond Li Fraumeni syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol 27:1250\u20131256. \nhttps:\/\/doi.org\/10.1200\/JCO.2008.16.6959","journal-title":"J Clin Oncol"},{"key":"2055_CR39","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/neuonc\/nox205","volume":"20","author":"J Hayes","year":"2018","unstructured":"Hayes J, Yu Y, Jalbert LE, Mazor T, Jones LE, Wood MD et al (2018) Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas. Neuro Oncol 20:632\u2013641. \nhttps:\/\/doi.org\/10.1093\/neuonc\/nox205","journal-title":"Neuro Oncol"},{"key":"2055_CR40","doi-asserted-by":"publisher","first-page":"8810","DOI":"10.1158\/0008-5472.CAN-07-1140","volume":"67","author":"B Hu","year":"2007","unstructured":"Hu B, Gilkes DM, Chen J (2007) Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMX. Cancer Res 67:8810\u20138817. \nhttps:\/\/doi.org\/10.1158\/0008-5472.CAN-07-1140","journal-title":"Cancer Res"},{"key":"2055_CR41","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1086\/374567","volume":"72","author":"SJ Hwang","year":"2003","unstructured":"Hwang SJ, Lozano G, Amos CI, Strong LC (2003) Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. Am J Hum Genet 72:975\u2013983. \nhttps:\/\/doi.org\/10.1086\/374567","journal-title":"Am J Hum Genet"},{"key":"2055_CR42","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1101\/gad.275891.115","volume":"30","author":"M Jennis","year":"2016","unstructured":"Jennis M, Kung CP, Basu S, Budina-Kolomets A, Leu JI, Khaku S et al (2016) An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model. Genes Dev 30:918\u2013930. \nhttps:\/\/doi.org\/10.1101\/gad.275891.115","journal-title":"Genes Dev"},{"key":"2055_CR43","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1146\/annurev.biochem.77.060806.091238","volume":"77","author":"AC Joerger","year":"2008","unstructured":"Joerger AC, Fersht AR (2008) Structural biology of the tumor suppressor p53. Annu Rev Biochem 77:557\u2013582. \nhttps:\/\/doi.org\/10.1146\/annurev.biochem.77.060806.091238","journal-title":"Annu Rev Biochem"},{"key":"2055_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3811","author":"C Jones","year":"2014","unstructured":"Jones C, Baker SJ (2014) Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma. Nat Rev Cancer. \nhttps:\/\/doi.org\/10.1038\/nrc3811","journal-title":"Nat Rev Cancer"},{"key":"2055_CR45","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature11284","volume":"488","author":"DT Jones","year":"2012","unstructured":"Jones DT, Jager N, Kool M, Zichner T, Hutter B, Sultan M et al (2012) Dissecting the genomic complexity underlying medulloblastoma. Nature 488:100\u2013105. \nhttps:\/\/doi.org\/10.1038\/nature11284","journal-title":"Nature"},{"key":"2055_CR46","doi-asserted-by":"publisher","DOI":"10.1101\/531210","author":"KJ Karczewski","year":"2019","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q et al (2019) Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. bioRxiv. \nhttps:\/\/doi.org\/10.1101\/531210","journal-title":"bioRxiv"},{"key":"2055_CR47","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","volume":"170","author":"ER Kastenhuber","year":"2017","unstructured":"Kastenhuber ER, Lowe SW (2017) Putting p53 in context. Cell 170:1062\u20131078. \nhttps:\/\/doi.org\/10.1016\/j.cell.2017.08.028","journal-title":"Cell"},{"key":"2055_CR48","doi-asserted-by":"publisher","first-page":"8424","DOI":"10.1073\/pnas.1431692100","volume":"100","author":"S Kato","year":"2003","unstructured":"Kato S, Han SY, Liu W, Otsuka K, Shibata H, Kanamaru R et al (2003) Understanding the function\u2013structure and function\u2013mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci USA 100:8424\u20138429. \nhttps:\/\/doi.org\/10.1073\/pnas.1431692100","journal-title":"Proc Natl Acad Sci USA"},{"key":"2055_CR49","first-page":"1","volume":"150","author":"P Kleihues","year":"1997","unstructured":"Kleihues P, Schauble B, Zur Hausen A, Esteve J, Ohgaki H (1997) Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol 150:1\u201313","journal-title":"Am J Pathol"},{"key":"2055_CR50","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ccr.2014.02.004","volume":"25","author":"M Kool","year":"2014","unstructured":"Kool M, Jones DT, Jager N, Northcott PA, Pugh TJ, Hovestadt V et al (2014) Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell 25:393\u2013405. \nhttps:\/\/doi.org\/10.1016\/j.ccr.2014.02.004","journal-title":"Cancer Cell"},{"key":"2055_CR51","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1158\/1078-0432.CCR-17-0408","volume":"23","author":"CP Kratz","year":"2017","unstructured":"Kratz CP, Achatz MI, Brugieres L, Frebourg T, Garber JE, Greer MC et al (2017) Cancer screening recommendations for individuals with Li\u2013Fraumeni syndrome. Clin Cancer Res 23:e38\u2013e45. \nhttps:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0408","journal-title":"Clin Cancer Res"},{"key":"2055_CR52","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.ejca.2005.01.026","volume":"41","author":"V Krutilkova","year":"2005","unstructured":"Krutilkova V, Trkova M, Fleitz J, Gregor V, Novotna K, Krepelova A et al (2005) Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations. Eur J Cancer 41:1597\u20131603. \nhttps:\/\/doi.org\/10.1016\/j.ejca.2005.01.026","journal-title":"Eur J Cancer"},{"key":"2055_CR53","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.celrep.2016.02.037","volume":"14","author":"CP Kung","year":"2016","unstructured":"Kung CP, Leu JI, Basu S, Khaku S, Anokye-Danso F, Liu Q et al (2016) The P72R polymorphism of p53 predisposes to obesity and metabolic dysfunction. Cell Rep 14:2413\u20132425. \nhttps:\/\/doi.org\/10.1016\/j.celrep.2016.02.037","journal-title":"Cell Rep"},{"key":"2055_CR54","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/(SICI)1522-2683(19990101)20:6<1204::AID-ELPS1204>3.0.CO;2-S","volume":"20","author":"LS Kutach","year":"1999","unstructured":"Kutach LS, Bolshakov S, Ananthaswamy HN (1999) Detection of mutations and polymorphisms in the p53 tumor suppressor gene by single-strand conformation polymorphism analysis. Electrophoresis 20:1204\u20131210. \nhttps:\/\/doi.org\/10.1002\/(SICI)1522-2683(19990101)20:6%3c1204:AID-ELPS1204%3e3.0.CO;2-S","journal-title":"Electrophoresis"},{"key":"2055_CR55","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S0140-6736(03)12856-5","volume":"361","author":"F Lalloo","year":"2003","unstructured":"Lalloo F, Varley J, Ellis D, Moran A, O\u2019Dair L, Pharoah P et al (2003) Prediction of pathogenic mutations in patients with early-onset breast cancer by family history. Lancet 361:1101\u20131102. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(03)12856-5","journal-title":"Lancet"},{"key":"2055_CR56","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S et al (2018) ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res 46:D1062\u2013D1067. \nhttps:\/\/doi.org\/10.1093\/nar\/gkx1153","journal-title":"Nucleic Acids Res"},{"key":"2055_CR57","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1128\/MCB.9.9.3982","volume":"9","author":"A Lavigueur","year":"1989","unstructured":"Lavigueur A, Maltby V, Mock D, Rossant J, Pawson T, Bernstein A (1989) High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Biol 9:3982\u20133991","journal-title":"Mol Cell Biol"},{"key":"2055_CR58","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T et al (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536:285\u2013291. \nhttps:\/\/doi.org\/10.1038\/nature19057","journal-title":"Nature"},{"key":"2055_CR59","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1158\/0008-5472.CAN-16-2179","volume":"77","author":"B Leroy","year":"2017","unstructured":"Leroy B, Ballinger ML, Baran-Marszak F, Bond GL, Braithwaite A, Concin N et al (2017) Recommended guidelines for validation, quality control, and reporting of TP53 variants in clinical practice. Cancer Res 77:1250\u20131260. \nhttps:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2179","journal-title":"Cancer Res"},{"key":"2055_CR60","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrc2723","volume":"9","author":"AJ Levine","year":"2009","unstructured":"Levine AJ, Oren M (2009) The first 30\u00a0years of p53: growing ever more complex. Nat Rev Cancer 9:749\u2013758. \nhttps:\/\/doi.org\/10.1038\/nrc2723","journal-title":"Nat Rev Cancer"},{"key":"2055_CR61","first-page":"1365","volume":"43","author":"FP Li","year":"1969","unstructured":"Li FP, Fraumeni JF Jr (1969) Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst 43:1365\u20131373","journal-title":"J Natl Cancer Inst"},{"key":"2055_CR62","doi-asserted-by":"publisher","first-page":"747","DOI":"10.7326\/0003-4819-71-4-747","volume":"71","author":"FP Li","year":"1969","unstructured":"Li FP, Fraumeni JF Jr (1969) Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med 71:747\u2013752","journal-title":"Ann Intern Med"},{"key":"2055_CR63","first-page":"5358","volume":"48","author":"FP Li","year":"1988","unstructured":"Li FP, Fraumeni JF Jr, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA et al (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48:5358\u20135362","journal-title":"Cancer Res"},{"key":"2055_CR64","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","volume":"19","author":"MM Li","year":"2017","unstructured":"Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S et al (2017) Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn 19:4\u201323. \nhttps:\/\/doi.org\/10.1016\/j.jmoldx.2016.10.002","journal-title":"J Mol Diagn"},{"key":"2055_CR65","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/0042-6822(79)90554-3","volume":"98","author":"DI Linzer","year":"1979","unstructured":"Linzer DI, Maltzman W, Levine AJ (1979) The SV40 A gene product is required for the production of a 54,000\u00a0MW cellular tumor antigen. Virology 98:308\u2013318","journal-title":"Virology"},{"key":"2055_CR66","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nature17157","volume":"531","author":"Y Liu","year":"2016","unstructured":"Liu Y, Chen C, Xu Z, Scuoppo C, Rillahan CD, Gao J et al (2016) Deletions linked to TP53 loss drive cancer through p53-independent mechanisms. Nature 531:471\u2013475. \nhttps:\/\/doi.org\/10.1038\/nature17157","journal-title":"Nature"},{"key":"2055_CR67","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK et al (2016) The 2016 World Health Organization Classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820. \nhttps:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"issue":"520\u2013537","key":"2055_CR68","doi-asserted-by":"publisher","first-page":"e525","DOI":"10.1016\/j.ccell.2017.08.017","volume":"32","author":"A Mackay","year":"2017","unstructured":"Mackay A, Burford A, Carvalho D, Izquierdo E, Fazal-Salom J, Taylor KR et al (2017) Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 32(520\u2013537):e525. \nhttps:\/\/doi.org\/10.1016\/j.ccell.2017.08.017","journal-title":"Cancer Cell"},{"key":"2055_CR69","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1126\/science.1978757","volume":"250","author":"D Malkin","year":"1990","unstructured":"Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH et al (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233\u20131238","journal-title":"Science"},{"key":"2055_CR70","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00401-014-1348-1","volume":"128","author":"J Mangerel","year":"2014","unstructured":"Mangerel J, Price A, Castelo-Branco P, Brzezinski J, Buczkowicz P, Rakopoulos P et al (2014) Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors. Acta Neuropathol 128:853\u2013862. \nhttps:\/\/doi.org\/10.1007\/s00401-014-1348-1","journal-title":"Acta Neuropathol"},{"key":"2055_CR71","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1158\/1078-0432.CCR-14-1324","volume":"21","author":"DM Merino","year":"2015","unstructured":"Merino DM, Shlien A, Villani A, Pienkowska M, Mack S, Ramaswamy V et al (2015) Molecular characterization of choroid plexus tumors reveals novel clinically relevant subgroups. Clin Cancer Res 21:184\u2013192. \nhttps:\/\/doi.org\/10.1158\/1078-0432.CCR-14-1324","journal-title":"Clin Cancer Res"},{"key":"2055_CR72","doi-asserted-by":"publisher","first-page":"e69026","DOI":"10.1371\/journal.pone.0069026","volume":"8","author":"G Mitchell","year":"2013","unstructured":"Mitchell G, Ballinger ML, Wong S, Hewitt C, James P, Young MA et al (2013) High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohort. PLoS One 8:e69026. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0069026","journal-title":"PLoS One"},{"key":"2055_CR73","unstructured":"National Comprehensive Cancer Network. Genetic\/familial high-risk assessment: breast and ovarian. Version 3.2019. \nhttps:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf\n\n. Accessed 18 Jan 2019"},{"key":"2055_CR74","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature22973","volume":"547","author":"PA Northcott","year":"2017","unstructured":"Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T et al (2017) The whole-genome landscape of medulloblastoma subtypes. Nature 547:311\u2013317. \nhttps:\/\/doi.org\/10.1038\/nature22973","journal-title":"Nature"},{"key":"2055_CR75","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-019-0063-6","volume":"5","author":"PA Northcott","year":"2019","unstructured":"Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC et al (2019) Medulloblastoma. Nat Rev Dis Primers 5:11. \nhttps:\/\/doi.org\/10.1038\/s41572-019-0063-6","journal-title":"Nat Rev Dis Primers"},{"key":"2055_CR76","first-page":"6643","volume":"63","author":"M Olivier","year":"2003","unstructured":"Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P et al (2003) Li\u2013Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 63:6643\u20136650","journal-title":"Cancer Res"},{"key":"2055_CR77","doi-asserted-by":"publisher","first-page":"a001008","DOI":"10.1101\/cshperspect.a001008","volume":"2","author":"M Olivier","year":"2010","unstructured":"Olivier M, Hollstein M, Hainaut P (2010) TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol 2:a001008. \nhttps:\/\/doi.org\/10.1101\/cshperspect.a001008","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2055_CR78","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/ng.1004","volume":"43","author":"TC Pansuriya","year":"2011","unstructured":"Pansuriya TC, van Eijk R, d\u2019Adamo P, van Ruler MA, Kuijjer ML, Oosting J et al (2011) Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat Genet 43:1256\u20131261. \nhttps:\/\/doi.org\/10.1038\/ng.1004","journal-title":"Nat Genet"},{"key":"2055_CR79","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/jmg.19.5.362","volume":"19","author":"AD Pearson","year":"1982","unstructured":"Pearson AD, Craft AW, Ratcliffe JM, Birch JM, Morris-Jones P, Roberts DF (1982) Two families with the Li\u2013Fraumeni cancer family syndrome. J Med Genet 19:362\u2013365","journal-title":"J Med Genet"},{"key":"2055_CR80","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/humu.20495","volume":"28","author":"A Petitjean","year":"2007","unstructured":"Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P et al (2007) Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 28:622\u2013629. \nhttps:\/\/doi.org\/10.1002\/humu.20495","journal-title":"Hum Mutat"},{"key":"2055_CR81","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1200\/JCO.2010.31.1670","volume":"28","author":"E Pfaff","year":"2010","unstructured":"Pfaff E, Remke M, Sturm D, Benner A, Witt H, Milde T et al (2010) TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. J Clin Oncol 28:5188\u20135196. \nhttps:\/\/doi.org\/10.1200\/JCO.2010.31.1670","journal-title":"J Clin Oncol"},{"key":"2055_CR82","doi-asserted-by":"publisher","first-page":"7435","DOI":"10.1038\/sj.onc.1205803","volume":"21","author":"GP Pfeifer","year":"2002","unstructured":"Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P (2002) Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21:7435\u20137451. \nhttps:\/\/doi.org\/10.1038\/sj.onc.1205803","journal-title":"Oncogene"},{"key":"2055_CR83","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1056\/NEJMoa012224","volume":"346","author":"IF Pollack","year":"2002","unstructured":"Pollack IF, Finkelstein SD, Woods J, Burnham J, Holmes EJ, Hamilton RL et al (2002) Expression of p53 and prognosis in children with malignant gliomas. N Engl J Med 346:420\u2013427. \nhttps:\/\/doi.org\/10.1056\/NEJMoa012224","journal-title":"N Engl J Med"},{"key":"2055_CR84","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature11329","volume":"488","author":"TJ Pugh","year":"2012","unstructured":"Pugh TJ, Weeraratne SD, Archer TC, Pomeranz Krummel DA, Auclair D, Bochicchio J et al (2012) Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488:106\u2013110. \nhttps:\/\/doi.org\/10.1038\/nature11329","journal-title":"Nature"},{"key":"2055_CR85","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-016-1569-6","volume":"131","author":"V Ramaswamy","year":"2016","unstructured":"Ramaswamy V, Remke M, Bouffet E, Bailey S, Clifford SC, Doz F et al (2016) Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Acta Neuropathol 131:821\u2013831. \nhttps:\/\/doi.org\/10.1007\/s00401-016-1569-6","journal-title":"Acta Neuropathol"},{"key":"2055_CR86","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2011.12.013","volume":"148","author":"T Rausch","year":"2012","unstructured":"Rausch T, Jones DT, Zapatka M, Stutz AM, Zichner T, Weischenfeldt J et al (2012) Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 148:59\u201371. \nhttps:\/\/doi.org\/10.1016\/j.cell.2011.12.013","journal-title":"Cell"},{"key":"2055_CR87","doi-asserted-by":"publisher","first-page":"7727","DOI":"10.18632\/oncotarget.3115","volume":"6","author":"S Ribi","year":"2015","unstructured":"Ribi S, Baumhoer D, Lee K, Edison Teo AS, Madan B et al (2015) TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li\u2013Fraumeni syndrome. Oncotarget 6:7727\u20137740. \nhttps:\/\/doi.org\/10.18632\/oncotarget.3115","journal-title":"Oncotarget"},{"key":"2055_CR88","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424. \nhttps:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"2055_CR89","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature11213","volume":"488","author":"G Robinson","year":"2012","unstructured":"Robinson G, Parker M, Kranenburg TA, Lu C, Chen X, Ding L et al (2012) Novel mutations target distinct subgroups of medulloblastoma. Nature 488:43\u201348. \nhttps:\/\/doi.org\/10.1038\/nature11213","journal-title":"Nature"},{"key":"2055_CR90","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1200\/JCO.2014.60.1591","volume":"33","author":"GW Robinson","year":"2015","unstructured":"Robinson GW, Orr BA, Wu G, Gururangan S, Lin T, Qaddoumi I et al (2015) Vismodegib exerts targeted efficacy against recurrent sonic hedgehog-subgroup medulloblastoma: results from phase II pediatric brain tumor consortium studies PBTC-025B and PBTC-032. J Clin Oncol 33:2646\u20132654. \nhttps:\/\/doi.org\/10.1200\/JCO.2014.60.1591","journal-title":"J Clin Oncol"},{"key":"2055_CR91","doi-asserted-by":"publisher","first-page":"a001016","DOI":"10.1101\/cshperspect.a001016","volume":"2","author":"AI Robles","year":"2010","unstructured":"Robles AI, Harris CC (2010) Clinical outcomes and correlates of TP53 mutations and cancer. Cold Spring Harb Perspect Biol 2:a001016. \nhttps:\/\/doi.org\/10.1101\/cshperspect.a001016","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2055_CR92","volume-title":"GeneReviews((R))","author":"K Schneider","year":"1993","unstructured":"Schneider K, Zelley K, Nichols KE, Garber J (1993) Li\u2013Fraumeni syndrome. In: Adam MP, Ardinger HH, Pagon RA et al (eds) GeneReviews((R)). University of Washington, Seattle, Seattle (WA)"},{"key":"2055_CR93","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S1470-2045(17)30243-7","volume":"18","author":"EC Schwalbe","year":"2017","unstructured":"Schwalbe EC, Lindsey JC, Nakjang S, Crosier S, Smith AJ, Hicks D et al (2017) Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study. Lancet Oncol 18:958\u2013971. \nhttps:\/\/doi.org\/10.1016\/S1470-2045(17)30243-7","journal-title":"Lancet Oncol"},{"key":"2055_CR94","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM et al (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29:308\u2013311. \nhttps:\/\/doi.org\/10.1093\/nar\/29.1.308","journal-title":"Nucleic Acids Res"},{"key":"2055_CR95","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1177\/1947601912455199","volume":"3","author":"D Shi","year":"2012","unstructured":"Shi D, Gu W (2012) Dual roles of MDM2 in the regulation of p53: ubiquitination dependent and ubiquitination independent mechanisms of MDM2 repression of p53 activity. Genes Cancer 3:240\u2013248. \nhttps:\/\/doi.org\/10.1177\/1947601912455199","journal-title":"Genes Cancer"},{"key":"2055_CR96","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10\u201329. \nhttps:\/\/doi.org\/10.3322\/caac.20138","journal-title":"CA Cancer J Clin"},{"key":"2055_CR97","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000154324","volume":"46","author":"A Sjalander","year":"1996","unstructured":"Sjalander A, Birgander R, Saha N, Beckman L, Beckman G (1996) p53 polymorphisms and haplotypes show distinct differences between major ethnic groups. Hum Hered 46:41\u201348. \nhttps:\/\/doi.org\/10.1159\/000154324","journal-title":"Hum Hered"},{"key":"2055_CR98","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.jocn.2012.04.009","volume":"19","author":"NR Smoll","year":"2012","unstructured":"Smoll NR, Drummond KJ (2012) The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children. J Clin Neurosci 19:1541\u20131544. \nhttps:\/\/doi.org\/10.1016\/j.jocn.2012.04.009","journal-title":"J Clin Neurosci"},{"key":"2055_CR99","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40291-013-0020-0","volume":"17","author":"AD Sorrell","year":"2013","unstructured":"Sorrell AD, Espenschied CR, Culver JO, Weitzel JN (2013) Tumor protein p53 (TP53) testing and Li\u2013Fraumeni syndrome: current status of clinical applications and future directions. Mol Diagn Ther 17:31\u201347. \nhttps:\/\/doi.org\/10.1007\/s40291-013-0020-0","journal-title":"Mol Diagn Ther"},{"key":"2055_CR100","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/35106009","volume":"1","author":"T Soussi","year":"2001","unstructured":"Soussi T, Beroud C (2001) Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 1:233\u2013240. \nhttps:\/\/doi.org\/10.1038\/35106009","journal-title":"Nat Rev Cancer"},{"key":"2055_CR101","first-page":"151","volume":"20","author":"LC Strong","year":"1989","unstructured":"Strong LC, Williams WR, Ferrell RE, Tainsky MA (1989) Genetic analysis of childhood sarcoma. Princess Takamatsu Symp 20:151\u2013157","journal-title":"Princess Takamatsu Symp"},{"key":"2055_CR102","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2016.01.015","volume":"164","author":"D Sturm","year":"2016","unstructured":"Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D et al (2016) New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164:1060\u20131072. \nhttps:\/\/doi.org\/10.1016\/j.cell.2016.01.015","journal-title":"Cell"},{"key":"2055_CR103","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1200\/JCO.2009.23.5952","volume":"28","author":"U Tabori","year":"2010","unstructured":"Tabori U, Baskin B, Shago M, Alon N, Taylor MD, Ray PN et al (2010) Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations. J Clin Oncol 28:1345\u20131350. \nhttps:\/\/doi.org\/10.1200\/JCO.2009.23.5952","journal-title":"J Clin Oncol"},{"key":"2055_CR104","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1200\/JCO.2009.26.8169","volume":"28","author":"U Tabori","year":"2010","unstructured":"Tabori U, Shlien A, Baskin B, Levitt S, Ray P, Alon N et al (2010) TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors. J Clin Oncol 28:1995\u20132001. \nhttps:\/\/doi.org\/10.1200\/JCO.2009.26.8169","journal-title":"J Clin Oncol"},{"key":"2055_CR105","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/bpa.12173","volume":"25","author":"H Takami","year":"2015","unstructured":"Takami H, Yoshida A, Fukushima S, Arita H, Matsushita Y, Nakamura T et al (2015) Revisiting TP53 mutations and immunohistochemistry\u2014a comparative study in 157 diffuse gliomas. Brain Pathol 25:256\u2013265. \nhttps:\/\/doi.org\/10.1111\/bpa.12173","journal-title":"Brain Pathol"},{"key":"2055_CR106","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00401-011-0922-z","volume":"123","author":"MD Taylor","year":"2012","unstructured":"Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC et al (2012) Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 123:465\u2013472. \nhttps:\/\/doi.org\/10.1007\/s00401-011-0922-z","journal-title":"Acta Neuropathol"},{"key":"2055_CR107","doi-asserted-by":"publisher","unstructured":"The Genomes Project C, Auton A, Abecasis GR, Altshuler DM, Durbin RM, Abecasis GR et al (2015) A global reference for human genetic variation. Nature 526:68. \nhttps:\/\/doi.org\/10.1038\/nature15393\n\n. \nhttps:\/\/www.nature.com\/articles\/nature15393#supplementary-information","DOI":"10.1038\/nature15393"},{"key":"2055_CR108","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1128\/MCB.19.2.1092","volume":"19","author":"M Thomas","year":"1999","unstructured":"Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G (1999) Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19:1092\u20131100","journal-title":"Mol Cell Biol"},{"key":"2055_CR109","first-page":"5718","volume":"61","author":"P Vahteristo","year":"2001","unstructured":"Vahteristo P, Tamminen A, Karvinen P, Eerola H, Eklund C, Aaltonen LA et al (2001) p53, CHK2, and CHK1 genes in Finnish families with Li\u2013Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition. Cancer Res 61:5718\u20135722","journal-title":"Cancer Res"},{"key":"2055_CR110","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/humu.10185","volume":"21","author":"JM Varley","year":"2003","unstructured":"Varley JM (2003) Germline TP53 mutations and Li\u2013Fraumeni syndrome. Hum Mutat 21:313\u2013320. \nhttps:\/\/doi.org\/10.1002\/humu.10185","journal-title":"Hum Mutat"},{"key":"2055_CR111","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98\u2013110. \nhttps:\/\/doi.org\/10.1016\/j.ccr.2009.12.020","journal-title":"Cancer Cell"},{"key":"2055_CR112","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S1470-2045(16)30249-2","volume":"17","author":"A Villani","year":"2016","unstructured":"Villani A, Shore A, Wasserman JD, Stephens D, Kim RH, Druker H et al (2016) Biochemical and imaging surveillance in germline TP53 mutation carriers with Li\u2013Fraumeni syndrome: 11\u00a0year follow-up of a prospective observational study. Lancet Oncol 17:1295\u20131305. \nhttps:\/\/doi.org\/10.1016\/S1470-2045(16)30249-2","journal-title":"Lancet Oncol"},{"key":"2055_CR113","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1470-2045(11)70119-X","volume":"12","author":"A Villani","year":"2011","unstructured":"Villani A, Tabori U, Schiffman J, Shlien A, Beyene J, Druker H et al (2011) Biochemical and imaging surveillance in germline TP53 mutation carriers with Li\u2013Fraumeni syndrome: a prospective observational study. Lancet Oncol 12:559\u2013567. \nhttps:\/\/doi.org\/10.1016\/S1470-2045(11)70119-X","journal-title":"Lancet Oncol"},{"key":"2055_CR114","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1097\/00005072-199811000-00009","volume":"57","author":"A Vital","year":"1998","unstructured":"Vital A, Bringuier PP, Huang H, San Galli F, Rivel J, Ansoborlo S et al (1998) Astrocytomas and choroid plexus tumors in two families with identical p53 germline mutations. J Neuropathol Exp Neurol 57:1061\u20131069","journal-title":"J Neuropathol Exp Neurol"},{"key":"2055_CR115","doi-asserted-by":"publisher","first-page":"15335","DOI":"10.1073\/pnas.93.26.15335","volume":"93","author":"KK Walker","year":"1996","unstructured":"Walker KK, Levine AJ (1996) Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci USA 93:15335\u201315340","journal-title":"Proc Natl Acad Sci USA"},{"key":"2055_CR116","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1470-2045(18)30242-0","volume":"19","author":"SM Waszak","year":"2018","unstructured":"Waszak SM, Northcott PA, Buchhalter I, Robinson GW, Sutter C, Groebner S et al (2018) Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Lancet Oncol 19:785\u2013798. \nhttps:\/\/doi.org\/10.1016\/S1470-2045(18)30242-0","journal-title":"Lancet Oncol"},{"key":"2055_CR117","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00401-009-0528-x","volume":"117","author":"T Watanabe","year":"2009","unstructured":"Watanabe T, Vital A, Nobusawa S, Kleihues P, Ohgaki H (2009) Selective acquisition of IDH1 R132C mutations in astrocytomas associated with Li\u2013Fraumeni syndrome. Acta Neuropathol 117:653\u2013656. \nhttps:\/\/doi.org\/10.1007\/s00401-009-0528-x","journal-title":"Acta Neuropathol"},{"key":"2055_CR118","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/gim.2017.196","volume":"20","author":"JN Weitzel","year":"2018","unstructured":"Weitzel JN, Chao EC, Nehoray B, Van Tongeren LR, LaDuca H, Blazer KR et al (2018) Somatic TP53 variants frequently confound germ-line testing results. Genet Med 20:809\u2013816. \nhttps:\/\/doi.org\/10.1038\/gim.2017.196","journal-title":"Genet Med"},{"key":"2055_CR119","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrc2584","volume":"9","author":"C Whibley","year":"2009","unstructured":"Whibley C, Pharoah PD, Hollstein M (2009) p53 polymorphisms: cancer implications. Nat Rev Cancer 9:95\u2013107. \nhttps:\/\/doi.org\/10.1038\/nrc2584","journal-title":"Nat Rev Cancer"},{"key":"2055_CR120","doi-asserted-by":"publisher","first-page":"8287","DOI":"10.1158\/0008-5472.CAN-05-4247","volume":"66","author":"CC Wu","year":"2006","unstructured":"Wu CC, Shete S, Amos CI, Strong LC (2006) Joint effects of germ-line p53 mutation and sex on cancer risk in Li\u2013Fraumeni syndrome. Cancer Res 66:8287\u20138292. \nhttps:\/\/doi.org\/10.1158\/0008-5472.CAN-05-4247","journal-title":"Cancer Res"},{"key":"2055_CR121","doi-asserted-by":"publisher","first-page":"e61662","DOI":"10.1371\/journal.pone.0061662","volume":"8","author":"D Wu","year":"2013","unstructured":"Wu D, Zhang Z, Chu H, Xu M, Xue Y, Zhu H et al (2013) Intron 3 sixteen base pairs duplication polymorphism of p53 contributes to breast cancer susceptibility: evidence from meta-analysis. PLoS One 8:e61662. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0061662","journal-title":"PLoS One"},{"key":"2055_CR122","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1200\/JCO.2012.48.5052","volume":"31","author":"N Zhukova","year":"2013","unstructured":"Zhukova N, Ramaswamy V, Remke M, Pfaff E, Shih DJ, Martin DC et al (2013) Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol 31:2927\u20132935. \nhttps:\/\/doi.org\/10.1200\/JCO.2012.48.5052","journal-title":"J Clin Oncol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-02055-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-019-02055-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-02055-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T19:32:29Z","timestamp":1598643149000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-019-02055-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,30]]},"references-count":122,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["2055"],"URL":"https:\/\/doi.org\/10.1007\/s00401-019-02055-3","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,30]]},"assertion":[{"value":"25 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}